.jpeg)
Nivolumab infusion time
Nivolumab (Nivolumab) is a liquid that is given intravenously (into a vein) over 30 minutes by a doctor or nurse at a hospital or medical facility. Nivolumab is administered as a 30-minute intravenous infusion, with the most common dosage regimen being 240 mg every two weeks or 480 mg every four weeks. When nivolumab is given in combination with ipilimumab or other chemotherapy drugs, it is usually given every 2, 3, or 4 weeks, depending on the indication. Nivolumab can be diluted with 9 mg/mL (0.9%) sodium chloride solution or 50 mg/mL (5%) dextrose for injection. Regardless of the diluent used, it is recommended to use it immediately after preparation of the solution.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
